Wikisage, the free encyclopedia of the second generation, is digital heritage

Eslicarbazepine: Difference between revisions

From Wikisage
Jump to navigation Jump to search
(Created page with "is an AED. Adjunctive eslicarbazepine led to seizure reduction in two patients with severe myoclonic epilepsy of infancy<ref>Severe myoclonic epilepsy o...")
 
mNo edit summary
Line 1: Line 1:
is an [[antiepileptic drug|AED]]. Adjunctive eslicarbazepine led to seizure reduction in two patients with severe myoclonic epilepsy of infancy<ref>Severe myoclonic epilepsy of infancy: Seizure reduction during adjunctive eslicarbazepine in two cases</ref>
is an [[antiepileptic drug|AED]]. Adjunctive eslicarbazepine led to seizure reduction in two patients with severe myoclonic epilepsy of infancy<ref>Severe myoclonic epilepsy of infancy: Seizure reduction during adjunctive eslicarbazepine in two cases</ref>
==Pharmacy and chemistry==
Eslicarbamazepine acetate is an once-daily antiepileptic that was approved in 2009 by the [[European Medicines Agency|EMA]] (Zerebix TM)<ref>[A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures]</ref>


<references/>
<references/>

Revision as of 02:39, 20 September 2015

is an AED. Adjunctive eslicarbazepine led to seizure reduction in two patients with severe myoclonic epilepsy of infancy[1]

Pharmacy and chemistry

Eslicarbamazepine acetate is an once-daily antiepileptic that was approved in 2009 by the EMA (Zerebix TM)[2]

  1. Severe myoclonic epilepsy of infancy: Seizure reduction during adjunctive eslicarbazepine in two cases
  2. [A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures]